Latest News...
Feb
15
Genomic and Personalized Medicine Postponed
It is with regret that we announce the Genomic and Personalized Medicine 2010 conference has been postponed. We will announce full details of the new conference dates shortly. We would like to take this opportunity to thank our dedicated sponsors, speakers and audience and look forward to meeting you at the newly scheduled Genomic and Personalized Medicine Conference soon.
Other Headlines...
Abstract submission deadline extended to 8 February 2010
12 Jan: 
We are pleased to announce the abstract submission deadline has been extended to the 8th February 2010 to allow authors extra time to complete their submissions. Submit your abstract online at www.genomicandpersonalizedmedicine.com
New speakers announced
12 Jan: 
We are delighted to present our invited speakers, who are now listed on the speakers page of the website. A select number of speakers also include their biographies – view them now on the speakers page.
FREE delegate place up for grabs!
4 Nov: 
We are offering the chance for one lucky winner to attend the Genomic and Personalized Medicine 2010 conference for FREE. Just submit your abstract by 11th December 2009 to be entered into the draw. The lucky winner will be informed by email in 2010.
Online registration open
2 Nov: 
We are pleased to announce the online registration system is live. Secure your delegate place today using the online registration system.
Abstracts for poster presentation are now invited
19 Aug: 
Abstracts should be submitted by 8 January 2010. For further details please see the abstract submission page.
Save 25% on Genomic and Personalized Medicine - Two-Volume Set
19 Aug: 
Conference attendees can save 25% by ordering online at: elsevierdirect.com/genomicandpersonalizedmedicine Full promotional details will be provided upon registration.
Elsevier announces Genomic and Personalized Medicine 2010
19 Aug: 
Genomic and Personalized Medicine 2010 will serve the needs of a wide group of stakeholders - practicing physicians, physician-scientists, industry leaders, policy makers, and other health care professionals and trainees at all levels. The conference will embrace one of the most promising avenues for advances in diagnosis, prevention, and treatment of human disease.
Back to Top